GENE ONLINE|News &
Opinion
Blog

Rajaneesh K. Gopinath

WRITTEN BY Rajaneesh K. Gopinath

Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Biogen’s ALS Drug Fails to Attain Primary Endpoint but Offers Hope With Secondary Outcomes
2021-10-18
AstraZeneca’s Imfinzi, Tremelimumab Combo Significantly Improves Overall Survival in Phase 3 Trials
2021-10-18
Apnimed’s Oral Drug for Obstructive Sleep Apnea Registers Encouraging Outcomes in Two Phase 2 Trials
2021-10-14
Takeda Inks $3.6 Billion Deal with Poseida to Advance Non-Viral Gene Therapies and Overcome Safety Issues
2021-10-13
Supernus Invests $400 Million to Acquire New Parkinson’s Assets from Adamas
2021-10-12
Takeda Embarks On a Billion-Dollar Gene Therapy Deal with Selecta Biosciences
2021-10-08
Expanding Deals and Investments Underscore Burgeoning Market of Targeted Protein Degradation
2021-10-07
WHO Approves Widespread Use of World’s First Malaria Vaccine
2021-10-06
Singapore Becomes Latest Asian Country to Sign Merck Deal for Oral COVID-19 Pill
2021-10-06
Discoverers of Temperature and Touch Receptors Win 2021 Nobel Prize in Medicine
2021-10-04
Merck Announces Its Oral COVID-19 Drug Cuts Risk of Hospitalization and Death by 50%
2021-10-01
Merck Acquires Acceleron for $11.5 Billion, Gaining Access to a Phase 3 Cardiovascular Asset
2021-09-30
Bispecific Antibodies or CAR T-Cells: Which One of These Cancer Immunotherapies Would Prevail?
2021-09-29
1 2 3 19
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!